Ozempic and Lobbying
The discussion dives into the stark contrast in Ozempic pricing between Europe and the U.S., highlighting the underlying issues within the healthcare system. With a major pharmaceutical company investing heavily in lobbying, the potential for a massive shift in business models is on the horizon. As Weight Watchers pivots to integrate Ozempic into their offerings, the financial implications could be significant, despite past losses. The conversation hints at a roller coaster ride ahead for the industry.In this clip
From this podcast
My First Million
The $70M/yr Sports Bar + Sleepy Industries Worth $100M
Related Questions
Why are prescription drugs so expensive as discussed in the episode The Dark, Untold Story of Ozempic and the clip Healthcare Cost Crisis?
What drives up prescription drug costs as discussed in the episode 615. Is Ozempic as Magical as It Sounds? | Freakonomics Radio and the clip Drug Pricing Solutions with Chronis Manolis?
Why is Ozempic cheaper in other countries?